🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel(s) Serving Size
90 Servings
Fat/Fatty Acid Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Calories
10 Calorie(s)
Evening Primrose Oil
1 Gram(s) (2% DV)
Linoleic Acid
910 mg
Gamma-Linolenic Acid
100 mg
Other Fatty Acids
290 mg

Other Ingredients

Gelatin Glycerin

Label Claims — Verification

Nutrient
All Other
Structure/Function

Target Groups

Adult Female (18 - 50 Years) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Suggested use As a dietary supplement, take 1 or 2 softgel capsules daily.

⚠️ Warnings & Precautions

Keep out of the reach of children.

Do not use if safety seal is damaged or missing.

🧪 Formulation Notes

Women's Primrose Oil A natural source of GLA.

Supports hormonal balance. Helps maintain smooth, healthy-looking skin.

Preservative free Gluten free No dairy Yeast free No artificial flavors No artificial colors No wheat Sodium free No soy No sugar No starch

Skin & hormonal health

910 mg linoleic acid (LA) per serving 100 mg gamma-linoleic (GLA) per serving

Non GMO

Conforms to USP <2091> for weight. Meets USP <2040> disintegration.

Additional Information

Store in a cool, dry place.

Typical Fatty Acid Profile Amount per serving Linoleic Acid (LA) (Omega-6) 910 mg Gamma-Linolenic (GLA) (Omega-6) 100 mg Other Fatty Acids 290 mg

Formulated in the USA Non GMO

Jer. 29:11

Product Details

UPC / SKU 8 50049 05208 5
DSLD Entry Date 2025-05-21
Product Type Fat/Fatty Acid
Form Capsule
DSLD ID 329698
Data Updated 2026-04-11

Research Evidence

We're building the evidence profile for this product's ingredients.

Our team is working to connect every product on the American market with peer-reviewed research. Check back soon for evidence-backed analysis.